BNY Mellon Long-Term Global Equity Fund USD X AccRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | 16.3 | 4.3 | |
+/-Cat | - | - | - | 0.3 | -2.2 | |
+/-B’mrk | - | - | - | -6.0 | -2.7 | |
Category: Global Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar Gbl Growth TME ... |
Key Stats | ||
NAV 02/05/2024 | USD 1.32 | |
Day Change | 0.51% | |
Morningstar Category™ | Global Large-Cap Growth Equity | |
ISIN | IE00BZ7MD267 | |
Fund Size (Mil) 28/03/2024 | EUR 1600.51 | |
Share Class Size (Mil) 02/05/2024 | USD 0.01 | |
Max Initial Charge | - | |
Ongoing Charge 07/11/2022 | 0.06% |
Investment Objective: BNY Mellon Long-Term Global Equity Fund USD X Acc |
The objective of the Sub-Fund is to achieve long-term capital appreciation through investing primarily (meaning at least three-quarters of the Sub-Fund’s total assets) in a portfolio of equity and equity related securities of companies located throughout the world. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Roy Leckie 04/04/2008 | ||
Charles Macquaker 04/04/2008 | ||
Click here to see others | ||
Inception Date 02/09/2022 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World NR EUR | Morningstar Gbl Growth TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BNY Mellon Long-Term Global Equity Fund USD X Acc | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 4.31 |
Microsoft Corp | Technology | 3.80 |
Taiwan Semiconductor Manufacturi... | Technology | 3.21 |
Linde PLC | Basic Materials | 3.05 |
Amphenol Corp Class A | Technology | 2.94 |
Increase Decrease New since last portfolio | ||
BNY Mellon Long-Term Global Equity Fund USD X Acc |